AzTrials
AzTrials

PulpotomiesNCT04634123

The Use of Portland Cement in Primary Anterior Teeth Pulpotomy.

A study testing Pulpotomy therapy by White Portland Cement and Pulpotomy therapy by White MTA in people with Pulpotomies, run by Damascus University at 1 site in Syria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effectiveness of White Portland cement and MTA in primary anterior teeth pulpotomy and follow up after 3 , 6 , 12 months ( Clinically and Radiographically) : Group A ( Control group ) : primary anterior teeth pulpotomized by White MTA . Read more about this study

Who is it for?
Ages 4 to 9 years
Conditions the study is for
Pulpotomies
What is being tested?
Pulpotomy therapy by White Portland Cement and Pulpotomy therapy by White MTA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteSyria
Study dates
1 Apr 2020to 1 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 9 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age between 4 and 9 years.
  • Definitely positive or positive ratings of Frank scale.
  • Caries include maximum two surfaces
  • Pulp exposure during caries removal
  • Pulpal hemorrhage light red acceptable to hemostasis
  • Physiological root resorption no more than the apical third
  • Absence clinical and radiographic signs which indicate pulp necrosis

Who cannot join

  • Systematic or mental disorders.
  • Definitely negative or negative ratings of Frankel scale
  • Existence periapical translucence
  • Existence external or internal abnormal absorption
  • Existence swelling or fistula
  • Sensitivity to percussion
  • Existence of spontaneous or stimulant pain
  • Excessive movement

Trial locations and contacts

1 site in 1 country.

Syria1 site
  • Damascus Universite

    Damascus

Other trials in Syria

About this study

Official title: Evaluation Using of White Portland Cement and MTA in Pulpotomy Primary Anterior Teeth

  • The aim of this study is to evaluate the effectiveness of White Portland cement and MTA in primary anterior teeth pulpotomy and follow up after 3 , 6 , 12 months ( Clinically and Radiographically) : Group A ( Control group ) : primary anterior teeth pulpotomized by White MTA . Group B : primary anterior teeth pulpotomized by White Portland Cement .
  • The aim of this study is to evaluate the effectiveness of White Portland cement and MTA in pulpotomy primary canines for serial extraction and extract them after 3 months for Histopathlogic study : Group A ( Control group ) : primary canines pulpotomized by White MTA . Group B : primary canines pulpotomized by White Portland Cement .
Read the detailed description
  • Endodontic therapy for primary teeth faces several difficulties including morphology of root canals , physiological root absorption and failure to find ideal root-filling paste absorbs the same degree of root absorption .
  • Pulpotomy therapy is considered easy , fast and does not include the length of canal or periapical region .
  • The split mouth design will be adopted for the treated samples .
  • Clinical success criteria :
  1. Absence of spontaneous or stimulant pain
  2. Absence gingival redness , swelling or fistula
  3. Physiological tooth mobility and absence sensitivity to percussion
  • Radiographically success criteria :
  1. Absence periapical translucence
  2. Absence external or internal abnormal absorption
Conditions
Pulpotomies
Being tested
Pulpotomy therapy by White Portland Cement, Pulpotomy therapy by White MTA
Keywords
Pulpotomy, Portland cement, Primary Anterior Teeth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulpotomy therapy by White Portland CementOther

    Carious asymptomatic primary anterior teeth will be removed of dental caries likely to produce vital pulp exposure . The access will be refined using a sterile no. 4 or 6 round bur in a slow-speed handpiece . The remaining pulp will be treated using pulpotomy therapy by White Portland Cement

  • Pulpotomy therapy by White MTAOther

    Carious asymptomatic primary anterior teeth will be removed of dental caries likely to produce vital pulp exposure . The access will be refined usinga sterile no. 4 or 6 round bur in a slow-speed handpiece . The remaining pulp will be treated using pulpotomy therapy by White MTA

Study groups in NCT04634123
Study groupRoleWhat they receive
Primary anterior teeth pulpotomy by White Portland CementExperimentalNot described
Receives: Other: Pulpotomy therapy by White Portland Cement
Primary anterior teeth pulpotomy by White MTAOtherNot described
Receives: Other: Pulpotomy therapy by White MTA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical evaluation of White Portland Cement pulpotomies 3 months after treatment

    Clinical evaluation of White Portland Cement pulpotomies was performed 3 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 3 months

  2. Clinical evaluation of White Portland Cement pulpotomies 6 months after treatment

    Clinical evaluation of White Portland Cement pulpotomies was performed 6 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 6 months

  3. Clinical evaluation of White Portland Cement pulpotomies 12 months after treatment

    Clinical evaluation of White Portland Cement pulpotomies was performed 12 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 12 months

  4. Clinical evaluation of White MTA pulpotomies 3 months after treatment

    Clinical evaluation of White MTA pulpotomies was performed 3 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 3 months

  5. Clinical evaluation of White MTA pulpotomies 6 months after treatment

    Clinical evaluation of White MTA pulpotomies was performed 6 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 6 months

  6. Clinical evaluation of White MTA pulpotomies 12 months after treatment

    Clinical evaluation of White MTA pulpotomies was performed 12 months after treatment using the preset clinical criteria. The pulpotomy procedure was decided a clinical success if the tooth fulfilled the following criteria: (1) No pain, (2) No swelling, (3) No tenderness to percussion, (4) No abscess or fistula, and (5) No abnormal tooth mobility

    Measured: 12 months

  7. Radiographic evaluation of White Portland Cement pulpotomies 3 months after treatment

    Radiographic evaluation of White Portland Cement pulpotomies was performed 3 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 3 months

  8. Radiographic evaluation of White Portland Cement pulpotomies 6 months after treatment

    Radiographic evaluation of White Portland Cement pulpotomies was performed 6 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 6 months

  9. Radiographic evaluation of White Portland Cement pulpotomies 12 months after treatment

    Radiographic evaluation of White Portland Cement pulpotomies was performed 12 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 12 months

  10. Radiographic evaluation of White MTA pulpotomies 3 months after treatment

    Radiographic evaluation of White MTAt pulpotomies was performed 3 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 3 months

  11. Radiographic evaluation of White MTA pulpotomies 6 months after treatment

    Radiographic evaluation of White MTAt pulpotomies was performed 6 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 6 months

  12. Radiographic evaluation of White MTA pulpotomies 12 months after treatment

    Radiographic evaluation of White MTAt pulpotomies was performed 12 months after treatment using periapical radiographs. The pulpotomized tooth was judged to be radiographically successful if it demonstrated the following criteria: (1) Normal periodontal ligament space (2) No periapical and furcation pathosis, and (3) No internal resorption. If pulp canal obliteration (PCO) happened, it was recorded but not considered as a treatment failure

    Measured: 12 months

  13. Histopathlogic evaluation of White Portland Cement 3 months after treatment

    Histopathlogical evaluation of White Portland Cement pulpotomies was performed 3 months after treatment using the preset histopathlogical criteria. The pulpotomy procedure was decided a histopathlogical success if the tooth fulfilled the following criteria: (1) Normal soft tissue, (2) Formulation dentin bridge, (3) Normal bleeding from pulp tissue, (4) No fibrosis, and (5) No pulp calcification

    Measured: 3 months

  14. Histopathlogic evaluation of White MTA 3 months after treatment

    Histopathlogical evaluation of White MTA pulpotomies was performed 3 months after treatment using the preset histopathlogical criteria. The pulpotomy procedure was decided a histopathlogical success if the tooth fulfilled the following criteria: (1) Normal soft tissue, (2) Formulation dentin bridge, (3) Normal bleeding from pulp tissue, (4) No fibrosis, and (5) No pulp calcification

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2020
  2. Study start1 Apr 2020
  3. Primary completion30 Nov 2020
  4. Study completion1 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Split mouth design
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04634123
Sponsor's protocol ID
UDDS-Pedo-02-2021
Status last verified
Nov 2021
First submitted
31 Jan 2020
Last updated
9 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nguyen TD, Judd PL, Barrett EJ, Sidhu N, Casas MJ. Comparison of Ferric Sulfate Combined Mineral Trioxide Aggregate Pulpotomy and Zinc Oxide Eugenol Pulpectomy of Primary Maxillary Incisors: An 18-month Randomized, Controlled Trial. Pediatr Dent. 2017 Jan 15;39(1):34-38.

    PubMed 28292339
  • Aminabadi NA, Farahani RM, Gajan EB. A clinical study of formocresol pulpotomy versus root canal therapy of vital primary incisors. J Clin Pediatr Dent. 2008 Spring;32(3):211-4. doi: 10.17796/jcpd.32.3.ghk26v4554790074.

    PubMed 18524271
  • Casas MJ, Kenny DJ, Johnston DH, Judd PL, Layug MA. Outcomes of vital primary incisor ferric sulfate pulpotomy and root canal therapy. J Can Dent Assoc. 2004 Jan;70(1):34-8.

    PubMed 14709254
  • Howley B, Seale NS, McWhorter AG, Kerins C, Boozer KB, Lindsey D. Pulpotomy versus pulpectomy for carious vital primary incisors: randomized controlled trial. Pediatr Dent. 2012 Sep-Oct;34(5):112-9.

    PubMed 23211895
  • Islam I, Chng HK, Yap AU. Comparison of the root-end sealing ability of MTA and Portland cement. Aust Endod J. 2005 Aug;31(2):59-62. doi: 10.1111/j.1747-4477.2005.tb00223.x.

    PubMed 16128253

Questions about this trial

What is this clinical trial studying?

A study testing Pulpotomy therapy by White Portland Cement and Pulpotomy therapy by White MTA in people with Pulpotomies, run by Damascus University at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical evaluation of White Portland Cement pulpotomies 3 months after treatment (time frame: 3 months). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04634123, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in